Citalopram ― lek antydepresyjny z grupy SSRI odkryty na nowo

Q4 Medicine
A. Czernikiewicz, Tomasz Horoch
{"title":"Citalopram ― lek antydepresyjny z grupy SSRI odkryty na nowo","authors":"A. Czernikiewicz, Tomasz Horoch","doi":"10.5603/psych.2020.0020","DOIUrl":null,"url":null,"abstract":"Citalopram is the most selective molecule in the class of selective serotonin reuptake inhibitors (SSRIs), except its active enantiomer S-citalopram. It belongs to the group of antidepressant and anxiolytic drugs, which is currently the standard in the treatment of depressive disorders and anxiety disorders with panic attacks, especially for the elderly. There is a lower risk of adverse interactions with other drugs because citalopram is metabolized by several CYP isoenzymes. The risk of sexual dysfunction caused by citalopram appears to be relatively smaller in comparison with other SSRIs.","PeriodicalId":39960,"journal":{"name":"Psychiatria","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2020-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Psychiatria","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5603/psych.2020.0020","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Citalopram is the most selective molecule in the class of selective serotonin reuptake inhibitors (SSRIs), except its active enantiomer S-citalopram. It belongs to the group of antidepressant and anxiolytic drugs, which is currently the standard in the treatment of depressive disorders and anxiety disorders with panic attacks, especially for the elderly. There is a lower risk of adverse interactions with other drugs because citalopram is metabolized by several CYP isoenzymes. The risk of sexual dysfunction caused by citalopram appears to be relatively smaller in comparison with other SSRIs.
西酞普兰——SSRI抗抑郁药被重新发现
西酞普兰是选择性5 -羟色胺再摄取抑制剂(SSRIs)中最具选择性的分子,其活性对映体s -西酞普兰除外。它属于抗抑郁和抗焦虑药物,是目前治疗伴有惊恐发作的抑郁症和焦虑症的标准药物,尤其适用于老年人。与其他药物发生不良反应的风险较低,因为西酞普兰被几种CYP同工酶代谢。与其他ssri类药物相比,西酞普兰引起性功能障碍的风险似乎相对较小。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Psychiatria
Psychiatria Medicine-Psychiatry and Mental Health
CiteScore
0.60
自引率
0.00%
发文量
0
期刊介绍: "Psychiatry" is a quaternary journal addressed to professionals coming from all branches of psychiatry practicing in both hospital and outpatients departments. "Psychiatry" issues original articles, reviews, case reports, commentaries, and translated articles from leading journals in the field of psychiatry. The papers are reviewed by the members of the editorial board. "Psychiatry" also publishes the practice guidelines in sexology. Psychopharmacotherapy is the main field of interests of the quatrernary.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信